__NUXT_JSONP__("/drugs/Ulocuplumab", (function(a,b,c){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:"1375830-34-4",chebiId:b,chemicalFormula:b,definition:"An orally bioavailable monoclonal antibody against CXC Chemokine Receptor 4 (CXCR4) with potential antineoplastic activity. Ulocuplumab binds to the chemokine receptor CXCR4, preventing the binding of stromal derived factor-1 (SDF-1) to the CXCR4 receptor and subsequent receptor activation, which may result in decreased tumor cell proliferation and migration. CXCR4, a chemokine receptor belonging to the G protein-coupled receptor family, plays an important role in chemotaxis and angiogenesis and is upregulated in several tumor cell types.",fdaUniiCode:"7KNP87L4X4",identifier:"C95755",preferredName:a,semanticType:"Pharmacologic Substance",subclassOf:["C20401"],synonyms:["BMS 936564","MDX-1338","ULOCUPLUMAB",a]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FUlocuplumab",extension:".json",createdAt:c,updatedAt:c}}],fetch:{},mutations:void 0}}("Ulocuplumab","","2021-10-30T13:48:09.333Z")));